Clinical Trials Arena on MSN21h
Enrolment concludes in Zealand’s Phase IIb obesity therapy trial
Zealand Pharma has concluded enrolment for its global, randomised Phase IIb ZUPREME-1 trial, assessing petrelintide.
Chemistry World22hOpinion
Weight loss drug supply races
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...
Novo Nordisk (NVO) to be ‘Market Leader’ Despite ‘Horrifying’ Declines
We recently published a list of 10 Stocks Market Experts are Talking About These Days. In this article, we are going to take ...
Sarepta plunges after death linked to Elevidys
Sarepta Therapeutics (SRPT) stock drops 25% as the company reports a patient death linked to Elevidys, its gene therapy developed with Roche (RHHBY). Read more here.